We've Got Receipts

    — Topic —

    GLP 1

    2 receipts tracked • 100% industry hit rate

    — Filed —

    2 receipts on GLP 1

    Browse all →

    RECEIPT #SCOTT-

    JAN 05, 2024

    Called it.

    PREDICTION BY

    Scott Galloway
    “If 2023 was the year of GPT-4, 2024 will be the year of GLP-1. That is, Ozempic, Mounjaro, and all GLP-1-related weight loss and diabetes treatment drugs.”

    FOLLOW-UP

    GLP-1 drugs did become a major economic and media narrative, with substantial market-cap gains for pharma and widespread discussion of their impact across various sectors, aligning with Galloway's prediction of it being the defining 'tech of the year' economically.

    ORIGINAL SOURCE

    No Mercy / No Malice
    GLP-1PharmaAIEconomy

    RECEIPT #SCOTT-

    JAN 05, 2024

    Called it.

    PREDICTION BY

    Scott Galloway
    “If 2023 was the year of GPT‑4, 2024 will be the year of GLP‑1. That is, Ozempic, Mounjaro, and all GLP‑1‑related weight loss technology. The first world’s most pressing health problem is not Covid, but obesity. The drug of the decade will be a weight loss drug, not a vaccine. The Tech of the Year, 2024: GLP‑1.”

    FOLLOW-UP

    GLP-1 drugs did become one of the most economically and culturally significant technologies in 2024, at least on par with mainstream AI coverage in business and consumer media.

    ORIGINAL SOURCE

    www.profgalloway.com
    HealthcareGLP-1Technology